Indirect comparison of changes of parameters of hemostasis during short-term use of ticlopidine and clopidogrel in patients with non-ST elevation acute coronary syndrome

Kardiologiya

Volumn 45, Issue 12, 2005, Pages 11-16

  Slavina, N N ^a   Averkov, O V ^a   Gratsiansky, N A ^a  

^a FEDERAL RESEARCH AND CLINICAL CENTER OF PHYSICAL CHEMICAL MEDICINE OF FEDERAL MEDICAL BIOLOGICAL AGENCY   (Russian Federation)

Author keywords

Clopidogrel; Hemostasis; Non ST elevation acute coronary syndrome, treatment; Ticlopidine

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DRUG DERIVATIVE; ENOXAPARIN; FIBRINOLYTIC AGENT; HEPARIN; THROMBIN; TICLOPIDINE;

ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ELECTROCARDIOGRAPHY; FIBRINOLYSIS; HEART INFARCTION; HEMOSTASIS; HUMAN; RANDOMIZED CONTROLLED TRIAL; SYNDROME; TIME;

ANTICOAGULANTS; ASPIRIN; ELECTROCARDIOGRAPHY; ENOXAPARIN; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; HEMOSTASIS; HEPARIN; HUMANS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; SYNDROME; THROMBIN; TICLOPIDINE; TIME FACTORS;

EID: 33645056982     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Braunwald E., Antman E.M., Beasley J.W. et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 2002;106:1893-1900.
2. Bertrand M.E., Simoons M.L., Fox K.A.A. et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 2002;23:1809-1840.
3. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
4. Mueller C., Buettner H.J., Petersen J. et al. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents. Circulation 2000;101:590-593.
5. Mueller C., Roskamm H., Neumann F.-J. et al. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents. J Am Coll Cardiol 2003;41:969-973.
6. Wolak, Amit, Cafri et al. Clopidogrel is associated with increased rates of long-term stent thrombosis and mortality as compared to ticlopidine following coronary stent implantation. Eur Heart J 2004;25,Abstr Suppl:Abstract 3704.
7. Herbert J.M., Frehel D., Vellee E. et al. Clopidogrel, a novel antiplatelet and antithrombotic agent. Cardiovasc Drug Rev 1993;11:180-198.
8. Hass W.K., Easton J.D. Ticlopidine, Platelets and Vascular Disease. New York: Springer Verlag 1993;33-70.
9. Montalescot G., Philippe F., Ankri A. et al. Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease. Beneficial effects of enoxaparin. Circulation 1998;98:294-299.
10. Jansson J.H., Olofsson B.O., Nilsson T.K. Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up. Circulation 1993;88:2030-2034.
11. Thompson S.G., Kienast J., Pyke S.D.M. et al. for the European Concerted Actions on Thrombosis and Disabilities Angina Pectoris Group. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. New Engl J Med 1995;332:635-641.
12. Scharfstein J.S., Abendschein D.R., Eisenberg P.R. et al. Usefulness of fibrinolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. Am J Cardiol 1996;78:503-510.
13. Pizzulli L., Zibres M., Yang A. et al. Mean platelet volume and platelet count as clinical marker for unstable angina and the extent of coronary artery disease. Eur Heart J 1995;Abstr Suppl: Abstract 2077.
14. Pizzulli L., Yang A., Zibres M. et al. Increase in mean platelet volume as parameter for restenosis following successful percutaneous transluminal coronary angioplasty. Circulation 1997;Abstr:Suppl:Abstract 928.